Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Oropharynx CancerFrailty
Interventions
RADIATION

Modified dose and fields intensity modulated radiotherapy

Instead of standard bilateral or extensive neck fields, the current radiation fields will cover disease with only 3cm expansion. The clinical target volumes doses are biologically equivalent to the standard but given in a shorter hypofractionated approach.

Trial Locations (1)

32207

RECRUITING

Baptist MD Anderson Cancer Center, Jacksonville

All Listed Sponsors
lead

Omar Mahmoud

OTHER